Roles Of CTLA4(CD 152)-CD80/CD86 Costimulatory Interactions In Modulation Of Primary Mouse CD4' T Cell Cycle Progression And Survival by Mukherjee, Sambuddho
Synopsis 
Roles of CTLA4 (CD152) - CDSO/CD86 Cost~mulatory Interact~ons in Modulation of 
Pnmary Mouse CD4' T Cell Cycle Progression and Surv~val 
Product~ve T cell actlvation requires the presence of a second 
(costrmulatory) srgnal, rn addrtion to the prrmary or first srgnal vra the T cell 
receptor CD28 is known to be the major T cell costrmulatory receptor, and 
rts engagement to its cognate Iigands, CD80 (87 1) and CD86 (B7 2) ,  greatly 
enhances T cell actlvation, prevents anergy and T cell death Another 
receptor, CD152 (CTLA4), shares signrfrcant homology to CD28 and brnds to 
the same Iigands, CD80 and CD86, but IS thought to play an rnhibrtory role In 
T cell actrvation However, some studres have suggested that CTLA4 may 
play a posit~ve role 
In vlvo, T cells experience a wide varrety of signals on bindrng of the 
TCR to  Major Histocompatrbility Complex (MHC)-peptrde complexes, In terms 
of affrnrty, avrdity, duratron, presentatron by different APCs, etc I n  the 
present work, the roles of CD28 and CTLA4 In enhancing or ~ n h i b ~ t ~ n g  T cell 
prolrferatron m v~tro were studled, using a prrmary cell culture system wrth 
hlghly purifred lymph node CD4' T cells from mice, different st~mulr and 
modes of presentation of antibodies to cell surface molecules Under soluble 
condrtrons, antr-CD28 triggers the CD28 receptor, whereas anti-CTLA4 blocks 
brnding of CTLA4 to CD80/CD86 In addition, the single charn fusron protern, 
mCTLA4hIgG1 brnds CD80/CD86 and b!ocks their interactrons with both 
CD28 and CTLA4 As CD80/CD86 on mouse T cells are hypoglycosylated and 
do not brnd to CD28, t h ~ s  T cell T cel! actrvation system allows in vitro study 
of the roles of CTLA4-CD80/CD86 rnteractlons Three actrvation models were 
employed to study the functional consequences of GTLA4-CD80/CD86 
interactions a) PMA+Ionomycrn; b) Concanavalrn A, and c) antr-CD3 Antr- 
CD28 tr~ggerrng, together wrth a primary signal, enhances proirferat~on of 
CD4+ T cells under all condrtrons studred The key findrng IS that blockade of 
CTLA4-CD80/CD86 rnteractrons, together wrth a prrmary stgnal, enhances 
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prolrferatron of primary CD4+ mouse T cells under some condrtrons (e g , 
activatron via plate bound anti-CD3), whereas the rdentrcal interactions 
inhibrt T cell activation In other modes of activatron (e g , mediated by 
PMA+Ionomycin) 
In~trally, CD4+ T cell act~vation mediated by pharmacologrcal agents, 
PMA (a constitutrve activator of Protein Krnase C) and Ionomycrn (a ca2' 
ionophore) which bypass the T Cell Receptor (TCR), was studred I n  the 
presence of CTLA4-CD80/CD86 blockade, lower induction of CD25 and BcIXL, 
reduced IL-2 secretion, enhanced TGFP product~on wrth concomrtant 
suppressron of mouse CD4' T cell prolrferatron wrth PMA+Ionomycrn is 
observed, extended CTLA4-blockade decreases cell cycle progressron and 
enhances apoptosis This inhrbrtion of T cell prolrferatron IS rescued 
completely with anti-CD28 or IL-2, but only partially wrth TGFp antagonists 
Further studies demonstrate that CTt44-CD80/CD86 rnteractrons In thrs 
CD4+ T cell act~vation model result in maintenance of caZf capacitance and 
membrane potential, and prevent the generation of excess reactrve oxygen 
species (ROS) and cell death Stud~es with CD4+ T cells from lpr mlce (with 
inactive Fas) and caspase-inhrbitors show that T cell death In thrs system IS 
Fas- and caspase-independent The addition of exogenous catalase in the 
culture medrum rescues CD4' T cell death and cell cycle progression 
observed on CTLA4-CDSO/CD86 blockade, indrcating that HzOz IS the primary 
ROS responsible for cellular Injury Studies wrth low concentratrons of 
Rotenone (a Complex Ionomycrn inhibrtor of the mrtochondrral electron 
transport cham) and Cyclosporrn A (prevents mitochondrral permeab~l~ty 
transition in the adenine nucleot~de tranporter pore by brndrng to cycloph~llln 
D) demonstrate a partial involvement of mrtochondrial derived ROS 
Importantly, lncreasrng amounts of Ionomycrn durrng CTLA4-CD80/86 
blockade and PMA+Ionomyc~n actrvatlon enhances cytoplasmic ca2+, 
partially lowers ROS levels and rescues T cell aeath and cell cycle arrest 
Together, these results rdent~fy ca2+ capacitance and H20z as med~ators of 
CTLA4-CD80/CD86 rnteractrons rn determining cell cycle progresslon and 
survival of CD4' T lymphocytes durlng actrvatron wlth PMA+Ionomycrn 
TCR slgnal strength IS known to regulate many key actrvatron and 
drfferentratlon programs ~n T cells While the costrmulatory functions of the 
key molecules, CD28 and CTLA4 are known, the modulation of this funct~on 
by the potency of the TCR srgnal rtself remains an actlve area of rnterest 
The rnfluence of strength and mode of primary srgnal through the TCR on 
functronal consequences of CD152-CD80/CD86 interactions were studled, 
employrng e~ther the lectin, Concanavalrn A (a polyclonal T cell mrtogen), or 
spectfic antibodies agarnst the CD3 complex Under lower (strmulatory) 
doses of Con A, CTL44-CD80/CD86 ~nteractlons enhance CD4+ T cell 
actlvatron, whereas the same lnteractlons inhlbrt cell cycle progression at 
hrgher (suppressive) doses owlng to rncreased oxrdatrve stress and 
decreased levels of BclXL. The enhanced cell death wrth hrgh Con A IS 
dependent on both HzOz and NO, but IS rndependent of Fas and caspases 
Most rnterestingly, rncreased prolrferatlon of CD4' T cells subjected to 
CTLA4-CD80lCD86 blockade at hrgher mrtogenrc doses IS, largely, IL-2 
Independent, but Cyclosporrn A sensltrve CTLA4-CD80/CD86 ~nteractlons at 
low doses of Con A enhance T cell actrvation and survival by reduclng the 
production of ROS, whrle s~multaneously lncreasrng IL-2 and BclXt levels 
Antr-CD3 rrnmobillzat~on onto a sol~d support matrrx IS known to 
generate strong slgnal, whereas the same antrbody In solutlon phase 
generates a much weaker signal We used thrs model to study the roles of 
CTL44-CD80/CD86 costlmulatory ~nterzctions on mode of signaling via the 
TCR/CD3 complex CTLA4-CD80/CD86 rnteractions wrth ~mmobllrzed antl- 
CD3 decrease IL-2 productron and cell cycle progresston On the other hand, 
the same rnteractrons enhance ca2+ capacitance and proliferation rn 
conjunctron w ~ t h  the weaker s~gnal delivered by soluble antr-CD3 An 
Increase In the srgnal dei~vered, usrng Ionomycrn, reverts the functional 
consequences of CTLA4-CD80/CD86 rnteractlons on actrvatron wlth soluble 
antr-CD3 Experiments wlth addrtron of exogenous IL-2 or  neutral~zatlon wrth 
anti-IL-2 demonstrated that IL-2 levels modulate the functional effects of 
these interactions with high amounts of IL-2, CTLA4-CD80/CD86 
interactions downmodulate T cell activation whereas with low amounts of IL-  
2, the same rnteractions enhance actrvatron Thus, these observations form 
the basis of a predictive model to  determine functional outcomes of CTLA4- 
CD80/CD86 interactions dependrng on the strength of the primary signal 
Finally, the primary mouse CD4+ T cell culture system wlth 
PMA+Ionomycin mediated actrvation and blockade of CD80/CD86 
costimulatory interactions was used as a robust screen for small molecules 
that rescued lowered T cell prol~feration Two small molecules, Naphthalene 
acet~c acid (NAA) and 2,4-Dichlorophenoxyacetrc acld (2,4-D), classrfred as 
synthetic plant growth modulators, that greatly enhance CD4+ T cell cycle 
progressron and survival, were identifled on the basis of enhanced 
prollferation Comparisons with structurally similar molecules reveal that the 
observed effects are highly specific NAA and 2,4-D enhance T cell actrvation, 
together wrth anti-CD3, by increasing levels of cytosolic ca2+, IL-2 and BclXL, 
and reducing ROS levels Importantly, these molecules do not act alone, but 
synergize with sub-optrmal signaling via the T cell receptor-CD3 complex, 
thereby acting as synthetic costimulators The impl~cations of plant growth 
modulators In enhancing T cell activatron are drscussed 
I n  summary, this thesis reports the setting up of highly purified 
primary mouse CD4+ T cell activation systems, the use of these systems rn 
elucidating the differential roles of CTLA4-CD80/CD86 ~nteractions, and 
finally, the use of the PMA+Ionomycin act~vatlon system as a screen for 
small molecule function In CD4' T cell cycle progresslon and surv~val The 
rmplications of this data on differential roles of CTLA4-CD80/CD86 
interactions depending on integrated signal strength and the potential use of 
CTLA4 based immunotherapy is discussed In context with the existing 
literature 
